Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelic Drugs in Biomedicine
Evan J. Kyzar, Charles D. Nichols, Raul R. Gainetdinov, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 11, pp. 992-1005
Closed Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly, Alexandra C. Greb, Lindsay P. Cameron, et al.
Cell Reports (2018) Vol. 23, Iss. 11, pp. 3170-3182
Open Access | Times Cited: 816
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
Matthew W. Johnson, Peter S. Hendricks, Frederick S. Barrett, et al.
Pharmacology & Therapeutics (2018) Vol. 197, pp. 83-102
Closed Access | Times Cited: 420
Effective connectivity changes in LSD-induced altered states of consciousness in humans
Katrin H. Preller, Adeel Razi, Peter Zeidman, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 7, pp. 2743-2748
Open Access | Times Cited: 257
Psychedelics as anti-inflammatory agents
Thomas W. Flanagan, Charles D. Nichols
International Review of Psychiatry (2018) Vol. 30, Iss. 4, pp. 363-375
Closed Access | Times Cited: 197
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
Danilo De Gregorio, Argel Aguilar‐Valles, Katrin H. Preller, et al.
Journal of Neuroscience (2020) Vol. 41, Iss. 5, pp. 891-900
Open Access | Times Cited: 185
Reviewing the Potential of Psychedelics for the Treatment of PTSD
Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 6, pp. 385-400
Open Access | Times Cited: 181
A systematic study of microdosing psychedelics
Vince Polito, Richard J. Stevenson
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0211023-e0211023
Open Access | Times Cited: 176
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 113
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 106
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
Danilo De Gregorio, Jelena Popić, Justine P. Enns, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 5
Open Access | Times Cited: 103
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 76
Effects of External Stimulation on Psychedelic State Neurodynamics
Pedro A. M. Mediano, Fernando E. Rosas, Christopher Timmermann, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 3, pp. 462-471
Open Access | Times Cited: 29
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Lindsay P. Cameron, Charlie J. Benson, Brian C. DeFelice, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 7, pp. 3261-3270
Open Access | Times Cited: 136
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials
Juan José Fuentes, Francina Fonseca, Matilde Elices, et al.
Frontiers in Psychiatry (2020) Vol. 10
Open Access | Times Cited: 136
Updating the dynamic framework of thought: Creativity and psychedelics
Manesh Girn, Caitlin Mills, Leor Roseman, et al.
NeuroImage (2020) Vol. 213, pp. 116726-116726
Open Access | Times Cited: 117
Mystical and Other Alterations in Sense of Self: An Expanded Framework for Studying Nonordinary Experiences
Ann Taves
Perspectives on Psychological Science (2020) Vol. 15, Iss. 3, pp. 669-690
Open Access | Times Cited: 94
Chronic pain and psychedelics: a review and proposed mechanism of action
Joel Castellanos, C. Leonard Woolley, Kelly Bruno, et al.
Regional Anesthesia & Pain Medicine (2020) Vol. 45, Iss. 7, pp. 486-494
Closed Access | Times Cited: 89
Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports
Charlotte Martial, Héléna Cassol, Vanessa Charland‐Verville, et al.
Consciousness and Cognition (2019) Vol. 69, pp. 52-69
Open Access | Times Cited: 82
Psychedelic Microdosing: Prevalence and Subjective Effects
Lindsay P. Cameron, Angela Nazarian, David E. Olson
Journal of Psychoactive Drugs (2020) Vol. 52, Iss. 2, pp. 113-122
Open Access | Times Cited: 82
The Enactive Approach to Habits: New Concepts for the Cognitive Science of Bad Habits and Addiction
Susana Ramírez–Vizcaya, Tom Froese
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 81
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
Bashkim Kadriu, Maximillian Greenwald, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 8-21
Open Access | Times Cited: 81
A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses
Tingying Chi, Jessica A. Gold
Journal of the Neurological Sciences (2020) Vol. 411, pp. 116715-116715
Open Access | Times Cited: 76
Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
Kristin Heuschkel, Kim P. C. Kuypers
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 74
Registered clinical studies investigating psychedelic drugs for psychiatric disorders
Ashley Siegel, Shakila Meshkat, Katie Benitah, et al.
Journal of Psychiatric Research (2021) Vol. 139, pp. 71-81
Closed Access | Times Cited: 69
Mescaline: The forgotten psychedelic
Ioanna A. Vamvakopoulou, Kelly A.D. Narine, Ian Campbell, et al.
Neuropharmacology (2022) Vol. 222, pp. 109294-109294
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top